A citation-based method for searching scientific literature

Takayuki Miki, Takahito Itoh, Daisuke Sunaga, Tetsuji Miura. Cardiovasc Diabetol 2012
Times Cited: 111







List of co-cited articles
1107 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity



Preconditioning the diabetic heart: the importance of Akt phosphorylation.
Andrew Tsang, Derek J Hausenloy, Mihaela M Mocanu, Richard D Carr, Derek M Yellon. Diabetes 2005
199
20


Cardioprotection with postconditioning: loss of efficacy in murine models of type-2 and type-1 diabetes.
Karin Przyklenk, Michelle Maynard, Dale L Greiner, Peter Whittaker. Antioxid Redox Signal 2011
102
19

Inhibition of myocardial injury by ischemic postconditioning during reperfusion: comparison with ischemic preconditioning.
Zhi-Qing Zhao, Joel S Corvera, Michael E Halkos, Faraz Kerendi, Ning-Ping Wang, Robert A Guyton, Jakob Vinten-Johansen. Am J Physiol Heart Circ Physiol 2003
18


Postconditioning the human heart.
Patrick Staat, Gilles Rioufol, Christophe Piot, Yves Cottin, Thien Tri Cung, Isabelle L'Huillier, Jean-François Aupetit, Eric Bonnefoy, Gérard Finet, Xavier André-Fouët,[...]. Circulation 2005
787
14

The diabetic heart: too sweet for its own good?
Hannah J Whittington, Girish G Babu, Mihaela M Mocanu, Derek M Yellon, Derek J Hausenloy. Cardiol Res Pract 2012
46
30

Infarct size, ejection fraction, and mortality in diabetic patients with acute myocardial infarction treated with thrombolytic therapy.
Jorge R Alegria, Todd D Miller, Raymond J Gibbons, Qi-Long Yi, Salim Yusuf. Am Heart J 2007
65
21

Comparison of myocardial reperfusion in patients undergoing percutaneous coronary intervention in ST-segment elevation acute myocardial infarction with versus without diabetes mellitus (from the EMERALD Trial).
Steven P Marso, Todd Miller, Barry D Rutherford, Raymond J Gibbons, Mansoor Qureshi, Anna Kalynych, Mark Turco, Heinz P Schultheiss, Roxana Mehran, Mitchell W Krucoff,[...]. Am J Cardiol 2007
86
16



Myocardial ischemic postconditioning against ischemia-reperfusion is impaired in ob/ob mice.
Omar Bouhidel, Sandrine Pons, Richard Souktani, Roland Zini, Alain Berdeaux, Bijan Ghaleh. Am J Physiol Heart Circ Physiol 2008
98
12

Myocardial reperfusion injury.
Derek M Yellon, Derek J Hausenloy. N Engl J Med 2007
12


Endoplasmic reticulum stress in diabetic hearts abolishes erythropoietin-induced myocardial protection by impairment of phospho-glycogen synthase kinase-3beta-mediated suppression of mitochondrial permeability transition.
Takayuki Miki, Tetsuji Miura, Hiroyuki Hotta, Masaya Tanno, Toshiyuki Yano, Takahiro Sato, Yoshiaki Terashima, Akifumi Takada, Satoko Ishikawa, Kazuaki Shimamoto. Diabetes 2009
96
12



Loss of cardioprotection with ageing.
Kerstin Boengler, Rainer Schulz, Gerd Heusch. Cardiovasc Res 2009
251
11

Release of a humoral circulating cardioprotective factor by remote ischemic preconditioning is dependent on preserved neural pathways in diabetic patients.
Rebekka Vibjerg Jensen, Nicolaj Brejnholt Støttrup, Steen Buus Kristiansen, Hans Erik Bøtker. Basic Res Cardiol 2012
106
11

Remote ischaemic conditioning before hospital admission, as a complement to angioplasty, and effect on myocardial salvage in patients with acute myocardial infarction: a randomised trial.
Hans Erik Bøtker, Rajesh Kharbanda, Michael R Schmidt, Morten Bøttcher, Anne K Kaltoft, Christian J Terkelsen, Kim Munk, Niels H Andersen, Troels M Hansen, Sven Trautner,[...]. Lancet 2010
745
11

Long-term benefit of postconditioning.
Hélène Thibault, Christophe Piot, Patrick Staat, Laurence Bontemps, Catherine Sportouch, Gilles Rioufol, Thien Tri Cung, Eric Bonnefoy, Denis Angoulvant, Jean-François Aupetit,[...]. Circulation 2008
333
10

Myocardial preconditioning against ischemia-reperfusion injury is abolished in Zucker obese rats with insulin resistance.
Prasad V G Katakam, James E Jordan, James A Snipes, Christina D Tulbert, Allison W Miller, David W Busija. Am J Physiol Regul Integr Comp Physiol 2007
106
10

Ischaemic preconditioning does not protect the heart in obese and lean animal models of type 2 diabetes.
S B Kristiansen, B Løfgren, N B Støttrup, D Khatir, J E Nielsen-Kudsk, T T Nielsen, H E Bøtker, A Flyvbjerg. Diabetologia 2004
111
10


The additive effects of ischemic postconditioning and cyclosporine-A on nitric oxide activity and functions of diabetic myocardium injured by ischemia/reperfusion.
Reza Badalzadeh, Mustafa Mohammadi, Moslem Najafi, Naser Ahmadiasl, Safar Farajnia, Hadi Ebrahimi. J Cardiovasc Pharmacol Ther 2012
40
25

Angiotensin II type 1 receptor-mediated upregulation of calcineurin activity underlies impairment of cardioprotective signaling in diabetic hearts.
Hiroyuki Hotta, Tetsuji Miura, Takayuki Miki, Nobuhiko Togashi, Takuto Maeda, Seok Jai Kim, Masaya Tanno, Toshiyuki Yano, Atsushi Kuno, Takahito Itoh,[...]. Circ Res 2010
54
18

Diabetes mellitus prevents ischemic preconditioning in patients with a first acute anterior wall myocardial infarction.
M Ishihara, I Inoue, T Kawagoe, Y Shimatani, S Kurisu, K Nishioka, Y Kouno, T Umemura, S Nakamura, H Sato. J Am Coll Cardiol 2001
135
10


Remote ischemic conditioning.
Gerd Heusch, Hans Erik Bøtker, Karin Przyklenk, Andrew Redington, Derek Yellon. J Am Coll Cardiol 2015
417
10

Improved long-term clinical outcomes in patients with ST-elevation myocardial infarction undergoing remote ischaemic conditioning as an adjunct to primary percutaneous coronary intervention.
Astrid D Sloth, Michael R Schmidt, Kim Munk, Rajesh K Kharbanda, Andrew N Redington, Morten Schmidt, Lars Pedersen, Henrik T Sørensen, Hans Erik Bøtker. Eur Heart J 2014
221
9

Postconditioning and protection from reperfusion injury: where do we stand? Position paper from the Working Group of Cellular Biology of the Heart of the European Society of Cardiology.
Michel Ovize, Gary F Baxter, Fabio Di Lisa, Péter Ferdinandy, David Garcia-Dorado, Derek J Hausenloy, Gerd Heusch, Jakob Vinten-Johansen, Derek M Yellon, Rainer Schulz. Cardiovasc Res 2010
410
9

Cardioprotective and prognostic effects of remote ischaemic preconditioning in patients undergoing coronary artery bypass surgery: a single-centre randomised, double-blind, controlled trial.
Matthias Thielmann, Eva Kottenberg, Petra Kleinbongard, Daniel Wendt, Nilgün Gedik, Susanne Pasa, Vivien Price, Konstantinos Tsagakis, Markus Neuhäuser, Jürgen Peters,[...]. Lancet 2013
337
9


Diabetes abolishes ischemic preconditioning: role of glucose, insulin, and osmolality.
J R Kersten, W G Toller, E R Gross, P S Pagel, D C Warltier. Am J Physiol Heart Circ Physiol 2000
177
9

Dipeptidyl peptidase-4 inhibitors and GLP-1 reduce myocardial infarct size in a glucose-dependent manner.
Derek J Hausenloy, Hannah J Whittington, Abigail M Wynne, Shah S Begum, Louise Theodorou, Niels Riksen, Mihaela M Mocanu, Derek M Yellon. Cardiovasc Diabetol 2013
74
12


Cardioprotection in the aging, diabetic heart: the loss of protective Akt signalling.
Hannah J Whittington, Idris Harding, Clemency I M Stephenson, Robert Bell, Derek J Hausenloy, Mihaela M Mocanu, Derek M Yellon. Cardiovasc Res 2013
67
13

Myocardial protection by remote ischaemic pre-conditioning is abolished in sulphonylurea-treated diabetics undergoing coronary revascularisation.
E Kottenberg, M Thielmann, P Kleinbongard, U H Frey, T Heine, H Jakob, G Heusch, J Peters. Acta Anaesthesiol Scand 2014
44
20

Mitochondrial dysfunction as the cause of the failure to precondition the diabetic human myocardium.
Ashraf Hassouna, Mahmoud Loubani, Bashir M Matata, Alan Fowler, Nicholas B Standen, Manuel Galiñanes. Cardiovasc Res 2006
95
9

Evolving therapies for myocardial ischemia/reperfusion injury.
Borja Ibáñez, Gerd Heusch, Michel Ovize, Frans Van de Werf. J Am Coll Cardiol 2015
561
9

Protection by remote ischemic preconditioning during coronary artery bypass graft surgery with isoflurane but not propofol - a clinical trial.
E Kottenberg, M Thielmann, L Bergmann, T Heine, H Jakob, G Heusch, J Peters. Acta Anaesthesiol Scand 2012
285
8

Ischemic postconditioning during primary percutaneous coronary intervention: the effects of postconditioning on myocardial reperfusion in patients with ST-segment elevation myocardial infarction (POST) randomized trial.
Joo-Yong Hahn, Young Bin Song, Eun Kyoung Kim, Cheol Woong Yu, Jang-Whan Bae, Woo-Young Chung, Seung-Hyuk Choi, Jin-Ho Choi, Jang-Ho Bae, Kyung Joo An,[...]. Circulation 2013
141
8

Glimepiride treatment facilitates ischemic preconditioning in the diabetic heart.
Derek J Hausenloy, Abigail M Wynne, Mihaela M Mocanu, Derek M Yellon. J Cardiovasc Pharmacol Ther 2013
27
29

Transient limb ischaemia remotely preconditions through a humoral mechanism acting directly on the myocardium: evidence suggesting cross-species protection.
Mikiko Shimizu, Michael Tropak, Roberto J Diaz, Fumiaki Suto, Harinee Surendra, Elena Kuzmin, Jing Li, Gil Gross, Gregory J Wilson, John Callahan,[...]. Clin Sci (Lond) 2009
230
8

Preconditioning the diabetic human myocardium.
Vivek Sivaraman, Derek J Hausenloy, Abigail M Wynne, Derek M Yellon. J Cell Mol Med 2010
65
12


Effect of early metoprolol on infarct size in ST-segment-elevation myocardial infarction patients undergoing primary percutaneous coronary intervention: the Effect of Metoprolol in Cardioprotection During an Acute Myocardial Infarction (METOCARD-CNIC) trial.
Borja Ibanez, Carlos Macaya, Vicente Sánchez-Brunete, Gonzalo Pizarro, Leticia Fernández-Friera, Alonso Mateos, Antonio Fernández-Ortiz, José M García-Ruiz, Ana García-Álvarez, Andrés Iñiguez,[...]. Circulation 2013
250
8

Failure to precondition pathological human myocardium.
S Ghosh, N B Standen, M Galiñianes. J Am Coll Cardiol 2001
113
8



Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.